Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
47 hedge funds and large institutions have $124M invested in Akoya BioSciences in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 18 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.47% less ownership
Funds ownership: 27.12% → 26.65% (-0.47%)
22% less funds holding
Funds holding: 60 → 47 (-13)
35% less capital invested
Capital invested by funds: $189M → $124M (-$65.6M)
72% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$13.6M |
| 2 |
HEC
Hudson Executive Capital
New York
|
+$13M |
| 3 |
Millennium Management
New York
|
+$4.14M |
| 4 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$3.21M |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$2.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$13.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.68M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$6.18M |
| 4 |
PA
Perceptive Advisors
New York
|
-$5.8M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$4.63M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
51
Perceptive Advisors
New York
| – | -$5.8M | -300,000 | Closed |
|
|
PVI
52
Pura Vida Investments
New York
| – | -$4.63M | -239,566 | Closed |
|
53
Balyasny Asset Management
Chicago,
Illinois
| – | -$1.62M | -83,619 | Closed |
|
54
Norges Bank
Oslo,
Norway
| – | -$1.25M | -64,872 | Closed |
|
|
CCM
55
CAAS Capital Management
New York
| – | -$977K | -50,500 | Closed |
|
56
Blackstone Inc
New York
| – | -$967K | -50,000 | Closed |
|
57
Alyeska Investment Group
Chicago,
Illinois
| – | -$906K | -46,825 | Closed |
|
|
MIM
58
Monashee Investment Management
Boston,
Massachusetts
| – | -$736K | -38,064 | Closed |
|
59
Walleye Capital
New York
| – | -$593 | -30,687 | Closed |
|
60
Marshall Wace
London,
United Kingdom
| – | -$471K | -24,357 | Closed |
|
|
ZP
61
Zimmer Partners
New York
| – | -$387K | -20,000 | Closed |
|
62
Tudor Investment Corp
Stamford,
Connecticut
| – | -$279K | -14,444 | Closed |
|
63
D.E. Shaw & Co
New York
| – | -$277K | -14,309 | Closed |
|
64
Walleye Trading
New York
| – | -$248K | -12,798 | Closed |
|
|
ASN
65
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -55 | Closed |
|
AKYA Hedge Fund Activity: Q3 2021 in Review
47 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q3 2021, worth a combined $124M — down 35% from $189M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of AKYA and 5 opened new positions — a net loss of 13 holders — while 15 trimmed existing stakes and 21 added.
The largest buyer was Polar Capital Holdings, adding an estimated $13.6M. The largest seller was Capital World Investors, exiting entirely with an estimated $13.5M sold.
- 47 institutional investors held Akoya BioSciences (AKYA) as of Q3 2021, down from 60 in Q2 2021.
- Funds reported $124M of Akoya BioSciences stock for Q3 2021, down 35% quarter-over-quarter.
- 5 funds opened new Akoya BioSciences positions in Q3 2021 and 18 closed out, a net change of -13 holders.
- The largest Akoya BioSciences buyer in Q3 2021 was Polar Capital Holdings, an estimated $13.6M added.
- The largest Akoya BioSciences seller in Q3 2021 was Capital World Investors, an estimated $13.5M sold.
Based on aggregated 13F filings for Q3 2021.